Lazic Antonije, Tilford J Mick, Martin Bradley C, Rezaeiahari Mandana, Goudie Anthony, Baghal Ahmad, Greer Melody
Department of Health Policy and Management, University of Arkansas for Medical Sciences, Little Rock, AR.
Division of Pharmaceutical Policy and Evaluation, University of Arkansas for Medical Sciences, Little Rock, AR.
Am J Med Open. 2024 Apr 24;12:100070. doi: 10.1016/j.ajmo.2024.100070. eCollection 2024 Dec.
Studies examining racial and ethnic disparities in-hospital mortality for patients hospitalized with COVID-19 had mixed results. Findings from patients within academic medical centers (AMCs) are lacking, but important given the role of AMCs in improving health equity.
The purpose of this study is to assess whether minority patients hospitalized with COVID-19 in National COVID Cohort Collaborative (N3C) institutions, which consist predominantly of AMCs, have higher mortality rates relative to White patients.
A retrospective analysis of patients hospitalized with COVID-19 was performed. Logistic regression analysis was used to test the primary hypothesis. A separate analysis tested whether there were differences by race and ethnicity during the delta variant phase of the pandemic.
All hospitalized patients with COVID-19 who were above 17 years old were categorized by race and ethnicity as Black, Hispanic, Asian, White, Other, and Unknown.
In-hospital mortality for patients with a known hospital outcome formed the primary outcome measure. Race and ethnicity were the primary independent variables.
There were 103,702 in-hospital Covid-19 admissions with 14,207 (13.7%) hospital deaths. Unadjusted in-hospital mortality for White patients was approximately 26% higher than for Black patients. After multivariable adjustment, none of the racial and ethnic groups had significantly different odds of in-hospital mortality compared to White patients. Only Hispanic patients had an odds ratio greater than one that was insignificant (OR = 1.06; 95% CI = 0.92-1.20). Findings for the delta variant phase were similar with the exception of the unknown category (OR = 1.90; 95% CI = 1.05-3.46).
Disparities in-hospital mortality outcomes by race or ethnicity were not found in COVID-19 patients hospitalized in AMCs. AMCs are expected to lead health delivery systems in eliminating disparities associated with structural racism. The null findings are consistent with the hypothesis of no difference in hospital outcomes by race or ethnicity in academic medical centers.
关于感染新型冠状病毒肺炎(COVID-19)住院患者院内死亡率的种族和民族差异的研究结果不一。学术医疗中心(AMC)内患者的相关研究结果尚缺,但鉴于AMC在改善健康公平性方面的作用,此类研究很重要。
本研究旨在评估在主要由AMC组成的国家COVID队列协作组织(N3C)机构中,感染COVID-19的少数族裔住院患者相对于白人患者是否有更高的死亡率。
对感染COVID-19的住院患者进行回顾性分析。采用逻辑回归分析来检验主要假设。另一项分析检验了在疫情的德尔塔变异株阶段,不同种族和民族之间是否存在差异。
所有17岁以上感染COVID-19的住院患者按种族和民族分为黑人、西班牙裔、亚裔、白人、其他和未知。
已知医院结局患者的院内死亡率构成主要结局指标。种族和民族是主要自变量。
共有103,702例COVID-19住院患者,其中14,207例(13.7%)住院死亡。白人患者未经调整的院内死亡率比黑人患者高约26%。多变量调整后,与白人患者相比,没有一个种族和民族组的院内死亡几率有显著差异。只有西班牙裔患者的优势比大于1,但无统计学意义(优势比 = 1.06;95%置信区间 = 0.92 - 1.20)。德尔塔变异株阶段的研究结果相似,但未知类别除外(优势比 = 1.90;95%置信区间 = 1.05 - 3.46)。
在AMC住院的COVID-19患者中未发现种族或民族导致的院内死亡差异。预计AMC将引领医疗服务系统消除与结构性种族主义相关的差异。这些阴性结果与学术医疗中心种族或民族在医院结局方面无差异的假设一致。